MyOme is a clinical genomics company that converts a single patient sample into comprehensive, actionable health insights. Using whole genome sequencing and proprietary bioinformatics—including integrated polygenic risk scores (iPRS)—MyOme delivers proactive and diagnostic tests covering risk assessment, medication response, and rare disease diagnostics. The platform supports providers and patients with clear reports, clinical summaries, education, and optional genetic counseling, while meeting high standards for privacy and security.